Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?

What this study is about

People with Multiple Sclerosis (MS) often experience cognitive difficulties such as memory problems, concentration issues, and reduced processing speed. These symptoms can have a negative impact on daily functioning and overall quality of life. Previous research on cognitive rehabilitation has shown that regular training focused on memory and concentration can have positive effects on cognitive functioning, including processing speed, memory, and executive functions that support daily activities. Moreover, fMRI studies (brain scans that measure brain activity) have revealed changes in brain activation following cognitive rehabilitation. Recently, the idea has emerged that a more personalized approach could improve treatment outcomes. Specifically, researchers have identified a link between personality traits and cognitive functioning. Since every individual is different, current cognitive rehabilitation programs often fail to take these personal differences into account. In this project, the investigators aim to enhance the effectiveness of cognitive rehabilitation by focusing more closely on individual characteristics through an app-based training program. Participants will complete a 12-week app training prior to a 6-week cognitive rehabilitation program. The first app focuses on mindset training, supported by a coach. Afterwards, all participants will use a second app designed to train processing speed and memory. In addition to cognitive functioning, the investigators will also examine psychological, (neuro)biological, and social changes using questionnaires and fMRI. This research may provide valuable insights into how cognitive functioning and quality of life in people with MS can be improved. This study is funded by the National MS Fund and is a collaboration between several institutions: the Department of Health, Medical and Neuropsychology at Leiden University (The Netherlands), the University at Buffalo (USA), and Reha Rheinfelden (Switzerland).

Who can join (things the study team will check)

✅ You may be able to join if…

• Confirmed relapsing remitting or secondary progressive MS diagnosis according to the McDonald 2017 criteria
• Expanded Disability Status Scale (EDSS) score < 7
• Relapse free period ≥ 3 months
• Unchanged disease modifying therapy for ≥ 2 months at time of inclusion
• Age 18-65 years
• Language Dutch, English or German for each centre respectively

🚫 You may not be able to join if…

• High conscientiousness, measured with a T score 65 or higher on the BFI-2 subscale for conscientiousness
• Current or prior brain trauma or neurological condition (other than MS)
• Psychiatric disorder that heavily impacts cognitive and/or daily functioning
• Medication intake and/or substance abuse that has an influence on cognitive functioning
• For Dutch subsample undergoing MRI: Contradiction for MRI

Where this trial is running

• Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo, Buffalo, New York, United States
• Health, Medical and Neuropsychology, Institute of Psychology, Faculty of Behvavioural and Social Siences, Leiden University, Leiden, Netherlands
• Research Department, Reha Rheinfelden, Rheinfelden, Switzerland

Who to contact

Charlotte C Rouzee, MSc · 062 831 93 32 · c.c.rouzee@fsw.leidenuniv.nl

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07225868.